ESSA Provides an Update on its Clinical Collaboration with Janssen

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Oct. 31, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that Janssen...

Click to view original post